chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the Covid-19 vaccine. He fainted immediately after receiving the vaccine. Pt regained consciousness within a few seconds. Pt looked clammy and pale but denied any dizziness. VS as follows:   At 1435: BP 98/39, HR 50, O2: 100 1440: BP 105/48, HR 48, O2: 99% 1450: BP 100/58, HR 54, O2: 100% Pt discharged home at 1450 in stable condition accompanied by mother
Chills, high fever symptoms for 24 hours, severe inflamed site of injection, allergic reaction, very red, warm, and itchy, felt sick and needed blankets to keep warm.
Hallucinations; Compulsive Behavior; Weakness; Falling; Confusion; This is a spontaneous report received from a contactable consumer (patient). A 73-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 11Mar2021 (Lot Number: EN6201) as 2nd dose, single for covid-19 immunization. The patient received the 1st dose of bnt162b2 (lot number EP6955) on 09Feb2021 in left arm for covid-19 immunization. Medical history included parkinsons. The patient had no other vaccine in four weeks, not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 post vaccination. Concomitant medications included rivastigmine (EXELON PATCH 10). The patient experienced hallucinations, compulsive behavior, weakness, falling, and confusion; all in Apr2021 with outcome of recovering. Therapeutic measures were taken as a result of the events and patient stopped taking exelon. The events resulted in doctor or other healthcare professional office/clinic visit.
After first shot-  racing heart, fever, severe shortness of breath. 2nd shot - fever, chills, nausea  3 Weeks out, sight of injection is suddenly painful - 3 days later-  fever, cough, light-headed
Provided Pentacel IZ which was given sooner than the recommended interval. Last IZ was at 15 months. Components of the combination drug require 6 months between and was given at 4.
pt recvd vax; in july 1995 broke out in full blown chicken pox;
FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) 98.9 F. On 18-MAR-2021, the subject experienced fever. On 19-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101.3 F, Approx 99. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever. This report was non-serious.
A 10-year-old male came in to receive his first dose of pediatric Pfizer vaccine. He stood up to walk away and he fell forward. Patient's mother caught him before hitting the ground, and yelled for help. Two nurses ran to assist client. He was turned around to lay face up on the floor. His legs were elevated on a chair. 16:22 vital signs: B/P: 90/60 O2: 98% HR:54. Client a/o x3, verbally responsive. Client sat on floor to drink a juice. He stated he started to see black and "just remembers falling to the ground." Patient's mom stated she saw her son turn green before he passed-out. She expected this as the same thing happened with her older son. Re-assessed vital signs at 16:25 B/P: 98/64 O2:98% HR: 67. He stated that he felt a lot better and can see clear now. Nurse advised mom on further adverse events and what to look for and when to take to ER or urgent care if needed, and recommended to stay 15 min still. Clients mother verbalized understanding. No other concerns noted or verbalized.
This spontaneous report as received from a Licensed Practical Nurse refers to a 38 year old male patient with ankylosing spondylitis and DEMEROL allergy. On 18-NOV-2014 the patient was vaccinated with PNEUMOVAX 23 (0.5 ml, intramuscular, in the arm, lot # K007262 with expiry date: 25-NOV-2015). Concomitant therapies included atorvastatin, baclofen, fluoxetine, HUMIRA and meloxicam. On 19-NOV-2014, the patient experienced severe muscle weakness and pain in the arm, redness and swelling from injection site, across the anterior arm to the axilla and difficulty moving the injection site, after receiving PNEUMOVAX 23. The patient was treated with an ice to site, KEFLEX and hydroxyzine. None lab diagnostics studies were performed. The patient sought medical attention via seeing the physician. The outcome of events was not reported. The relatedness between events and PNEUMOVAX 23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Patient c/o right throat swelling approx. 10 min after receiving COVID vaccination. Denied shortness of breath, no difficulty swallowing, no rash or itching, no nausea.  Denied feeling light headed or dizzy. Able to speak clearly. Injection site to right arm was fine. BP 151/104 pulse 104 o2 sat 97% Given 60 mg of fexofenadine at 11:35 AM.  Continued to c/o throat  swelling, some throat discomfort rated 2/10 on pain scale  C/O some numbness to lips at 11:50 AM   B/P 151/101 pulse 104 O2 sat 98% Escorted patient via wheelchair to hospital ER dept   further evaluation
I had no strength in my left arm as well as severe soreness. I also had fatigue, body aches and chills and a 103 fever
Pt had erythematous conjunctiva with yellow crusting, audible wheezing and sob.  Pt was given 50 mg benadryl IM, an albuterol treatment, and depomedrol 40 mg.  Pt also given a prescription for medrol dose pack.  Pt vomited during breathing treatment and following treatment.  Pt's wheezing had disappeared after breathing treatment.  Monitored pt.
Information has been received from a physician concerning a 12 year old female with no pertinent medical history or allergies who in April 2008, was vaccinated intramuscularly with a first dose of GARDASIL vaccine live (yeast) and no problems were reported. "About 2 weeks ago", in June 2008, the patient was vaccinated intramuscularly with a second dose of GARDASIL vaccine (yeast). There was no concomitant medication. The same night of the second vaccination, the patient experienced muscle pain in the legs and arms and had a general feeling of weakness all over. No laboratory or diagnostics studies were performed. The myalgia lasted 48 to 72 hours. Subsequently, the patient recovered from myalgia. Additional information has been requested.
She experienced flushing, heart palpitations, and spotted vision.  PT was laid on the ground with her feet elevated.  Symptoms resolved within a few seconds and did not return.  Entire evented lasted no more than 10 minutes
herpes simplex keratitis; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about 14-JAN-2017 , the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for routine health maintenance and for  the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving zoster vaccine live (ZOSTAVAX), the patient was diagnosed with herpes simplex keratitis. The patient's symptoms resulted in physical limitations which were not present prior to using zoster vaccine live (ZOSTAVAX). It was also specified that the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life and physical impairment. The event herpes simplex keratitis was considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.   Upon internal review,ophthalmic herpes simplex was considered to be medically significant. The event was considered to be disabling due to the severe, permanent and incurable injuries.
Patient complaint of redness at injection sites, nausea, pain, swelling for 1-2 days
This spontaneous report as received from a certified medical assistant concerning a patient of unknown age and gender who on 05-SEP-2012 was vaccinated with subcutaneously with an expired dose of M-M-R II, lot number 67246/0907, expired date 09-JUL-2012. No adverse events were reported. Additional information has been requested.
permanent a-fib; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FIBRILLATION (permanent a-fib) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cardiac ablation (in 2015).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ATRIAL FIBRILLATION (permanent a-fib) (seriousness criterion medically significant). At the time of the report, ATRIAL FIBRILLATION (permanent a-fib) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, Electrocardiogram: permanent a-fib (abnormal) permanent a-fib.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were reported.  The patient had medical history of an ablation in 2015. Then he had no more a-fib until the second Moderna vaccine. On 05-Feb-2021, his heart started to dance around in his chest. It would go very slow, then it would take off like a motor boat and go extremely fast. It took him about 4 hours of different techniques to get this under control. His cardiologist took an EKG in Jul-2021 and said you're in permanent a-fib. They did a cardioversion a couple of weeks ago.  The patient reports having a cardioversion in Aug-2021.  No treatment medication details was reported.  Company Comment Based on the current available information and temporal association between the use of the product and the start date of the event (atrial fibrillation), a causal relationship cannot be excluded. However, as per the reported information, the medical history of ablation (probably indicates pre-existing atrial fibrillation in this patient) and is a confounder for the occurrence of the event.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event (atrial fibrillation), a causal relationship cannot be excluded. However, as per the reported information, the medical history of ablation (probably indicates pre-existing atrial fibrillation in this patient) and is a confounder for the occurrence of the event.
(L) arm around the shot became very red and hot, 101 degree fever. Primary Doctor gave prednisone, KEFLEX. Arm swelled immediately. Had an appointment 3 PM Dr. observed and diagnosed. Get BENADRYL and return to where I received the shot. Saw primary after few days he felt shot was given too high on arm probably in muscle.
Covid booster given to a patient 4 months after booster already received. Patient forgot they previously got the covid Pfizer booster.
4 weeks after booster had sudden onset vertigo drop attack with uncontrollable vomiting, profuse sweating and rigors. Developed low tone earing deficits in the left ear. Had subsequent second vertigo attack 2 days later with near-similar severity. Sought care on 11/5 d/t hearing impairment - started high dose steroids for possible vestibular or labyrinth neuritis. Continued to have episodes of debilitating sudden onset vertigo since that time
this is 1 of 4 pt, out of 35 to devel an inj site rxn, characterized by redness & itching, immed p/vax;pt also exp itching in the opposite arm;
Significant blurring of vision in right eye.  It appears like "floaters" but so much so that I can't see well.  It moves like there is a fluid (blood?) inside my eye, and areas around and beneath the debris are extremely blurry, while other parts of the visual field are still clear.  It's not like there are dead spot on the retina, more like dark fluid swirling around in my visual field.  No redness or pain, just visual loss.
a red swelling for 3 daysand  It has a red ring around it, a good probably like 5 inches; my arm swelled up again; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (a red swelling for 3 daysand  It has a red ring around it, a good probably like 5 inches) and PERIPHERAL SWELLING (my arm swelled up again) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (a red swelling for 3 daysand  It has a red ring around it, a good probably like 5 inches) and PERIPHERAL SWELLING (my arm swelled up again). At the time of the report, VACCINATION SITE ERYTHEMA (a red swelling for 3 daysand  It has a red ring around it, a good probably like 5 inches) and PERIPHERAL SWELLING (my arm swelled up again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Starting on April 4 (2 days after 1st vaccine dose) I got a rash and intense itching on my legs, arms, and back. I had a virtual Dr appointment on April 8 where I was recommended to use hydrocortisone, benadryl at night, and double my normal allergy medicine (Allegra). It didn't clear up so I went to an in person appointment on April 12, where the doctor ran several tests, and since they all came back normal gave me a 3 day course of prednisone, which cleared up the itching and rash. After the second vaccine dose I had a similar reaction but less severe. I was prescribed prednisone again which cleared it up again.  After the third dose (booster) I had no reaction.
On 04/24/2021, 2 minutes after the Pfizer immunization given to patient, complained of not feeling well. As soon as the pharmacist ran to help her, she looks seriously pale, nauseous, sweaty, and then lost all her faculty. She said she could not see anything and started to feel difficult of breathing. The pharmacist immediately gave her EpiPen, and called 911. While waiting for EMS, she started to feel a bit better, could see things. EMS came, measured her blood pressure, and told that she got syncope. They transported her to the hospital.
Pt. due for COVID booster (dose #3).Provider ordered bivalent COVID vaccine, 5-11 yrs. old ORANGE CAP for patient, but monovalent COVID vaccine, 5-11 years old ORANGE CAP was administered.
Rectal cancer - hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
We noticed our child?s eyes crossing the morning of 02/16/2020. By Wednesday, 02/19/2020, her left eye was completely turned inward (esotropia) and the left side of her face was drooping. She was not acting like herself which warranted a visit to her doctor. We saw the doctor on Thursday, 02/20/2020, where he completed a physical exam and suggested we go to the emergency room at the Medical hospital for a MRI. That evening, the MRI showed a normal brain scan without abnormalities. Given her history, it was determined that she had sixth cranial nerve palsy, most likely caused by her recent MMR vaccination.
Shingles Two rounds of steroids and Valtrex Pain, then rash, very sensitive skin, cured inapprox. 4 wks. after starting treatment.
Pt developed 2/28 went to peds, flu neg. Seen by me 3/1 with fever and complaint of leg pains and had normal exam. Dx with viral illness. Then on early am 3/3 went to ED for joint swelling. They did CBC, ESR, CK all normal. Came to see me in office morning of 3/3. Noted to have swelling of right knee. Advised most likely toxic synovitis. Then went back to ED later that night (seen by me at hospital) and he had swelling of both hands and feet and still the right knee, temp of 100F and diffuse urticarial rash. Dx with serum sickness. The only new med etc is the flu shot and PREVNAR vaccine. Did get MOTRIN when he had fever.
Severe non stop ringing in my right ear. It sounds like I have an earphone in that is playing non-stop static or high pitched ringing in my ear, and it feels like there is pressure.
Report MS flare up (trouble walking, walk with a shuffle).  Treatment will follow up with treating provider.
Pt called 42 hrs p/receiving the vax pt stated rt arm became reddened, swollen, & warm to touch w/in 24 hrs; further stated the sx were lessened & continuing to improve @ this time;
1/2 hr p/vax pt exp swelling & itching & black & blue discoloration around sit of inject; called PHU advised to apply ice to site & take DPH advised to apply ice to site & take DPH; pt relates DPH & ice relieved swelling -peruritis persiste
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Neck and shoulder pain.  Icepack. Will take Tylenol when she gets home
On 01/09/2001 pt received Td booster im right deltoid. Pt reported to health facility on 01/12/2001 that she became dizzy, nauseous, and experienced chills and fever, and vomiting shortly after Td administration. Injection site was swollen, red and sore to touch. Symptoms resolved on 01/16/2001.
Immune thrombocytopenia purpuria; bleeding of gums, nose, skin pricks; bleeding of gums, nose, skin pricks; bleeding of gums, nose, skin pricks; platelet count of 1000; This is a spontaneous report from a contactable nurse reported for herself.  This 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number  ELU266), via an unspecified route of administration at single dose in left arm on 20Feb2021 12:45 for COVID-19 immunisation. Medical history included allergies to medications penicillins, ceclor, statins, environmental; diabetes; hypertension; asthma; gastrooesophageal reflux disease. The vaccine was administered at Health Clinic. Concomitant medications included rabeprazole, clonazepam, montelukast, venlafaxine hydrochloride. On 22Feb2021, the patient experienced immune thrombocytopenia purpuria, bleeding of gums, nose, skin pricks, platelet count of 1000. Therapeutic measures were taken as a result of the events included steroids, IVGM, platelets, PRBC, iron, antibiotics. The outcome of the events was recovering. The patient was hospitalized and condition was life threatening. The patient underwent lab tests and procedures which included platelet count: 1000 on 22Feb2021, SARS-CoV-2 test: negative on 07Mar2021.; Sender's Comments: A contributory role of the vaccine BNT162B2 to reported events cannot be excluded based on plausible temporal relationship and lack of alternate explanation at this time. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Severe lower extremity weakness resulting in multiple falls, loss of popliteal reflexes bilaterally, numbness and tingling of bilateral hands, dizziness. Ongoing symptoms still, 20 months post vaccine.
Herpes Zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 54 years old male patient. Information regarding medical history, concurrent conditions, or concomitant medications was not provided. In 2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified), for the long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient experienced Herpes Zoster. On an unspecified date, the patient was treated by a family nurse practitioner for Herpes Zoster. The outcome of Herpes Zoster was unknown. The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).  Additional information has been requested.
Temperature more than 100 Fahrenheit, chills, headache, weakness, temperature goes up and down every 30 minutes.
Right deltoid swelling, itching, erythema, local pain, sight is hot.  Vaccine was adminstered on 7 Dec 02, approximately 0800 hrs. Member reported to the US Army Health clinic for evaluation.  Patient was given Motrin and cold compresses.  Patient was educated to report to emergency care is symptoms worsen.  Annual follow up on 01/06/04: "Vaccine recipient has recovered from adverse event that was reported for this vaccination."
Patient admitted to skilled nursing, current diagnosis and symptoms before during and after vaccine is diarrhea, chills, shaking and fatigue. Unknown if side effect of vaccine or due to medical condition.
Itching/redness and swelling (R) arm 7" x 5" round (L) arm redness.
Experiencing similar symptoms of those of heart failure; Feeling bad; Congestion; Coughing a lot; Tired alot; A spontaneous report was received from a consumer concerning an 82-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA -1273) and experienced feeling bad/feeling abnormal, had similar symptoms of those of heart failure/cardiac failure, coughing a lot/cough ,congestion/nasal congestion and tired a lot/fatigue.  The patient's medical history included heart failure and hypothyroidism. Concomitant medications reported included medication for heart failure and hypothyroidism.  On 19-JAN-2021, approximately three weeks prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 10-FEB-2021, the patient reported that three weeks after receiving the vaccine she started feeling bad, had similar symptoms of those of heart failure (which he has had), cough/coughing a lot, congestion and tired a lot. The event similar symptoms of those of heart failure is considered as medically significant. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events feeling bad, similar symptoms of those of heart failure, cough (coughing a lot),congestion and tired a lot, were unknown.; Reporter's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Chills started 11pm day of shot.. Headache started shortly after. Aches pains especially in legs , fever, and sore injection area.
first dose on 20Apr2021 and had positive COVID-19 test on 27Apr2021; This is a spontaneous report from a contactable consumer (patient) via a Pfizer Sponsored Program. A male patient of unspecified age received BNT162VB2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Apr2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient received his first dose on 20Apr2021 and had positive COVID-19 test on 27Apr2021.  The patient will be off quarantine on 07May2021. The patient was scheduled to receive his second dose on 11May2021. Outcome of the event was unknown.   Information on the lot/batch number has been requested.